概述
                - 
                        
货号
DHJ70122
 - 
                                
表达系统
Mammalian Cells - 
                                
种属反应性
Human - 
                                
同种型
Fusion - [CD80 (B7-1, CD28LG1) fragment (1-107)]2 - IGHG1 Fc (Fragment constant) - 
                                
靶标
B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, CD28, TP44, T-cell-specific surface glycoprotein CD28, CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4 - 
                                
浓度
1 mg/ml - 
                                
内毒素水平
Please contact with the lab for this information. - 
                                
纯度
>95% as determined by SDS-PAGE. - 
                                
纯化方式
Protein A/G purified from cell culture supernatant. - 
                                
Accession号
Q9NZQ7 & P10747 & P16410 - 
                                
克隆号
Davoceticept
 - 
                                
应用
Research Grade Biosimilar - 
                                
状态
Liquid - 
                                
保存溶液
0.01M PBS, pH 7.4. - 
                                
稳定性和存储
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. - 
                                
别名
ALPN-202,CD80 vIgD-Fc, CAS: 2307144-64-3
 
图片
                参考文献
                评价
                




